期刊文献+

复方倍他米松注射液局部注射治疗瘢痕疙瘩和增生性瘢痕的多中心研究 被引量:7

Intralesional injection of compound betamethasone for the treatment of keloid and hyperplastic scar: a multi-center study
原文传递
导出
摘要 目的评价国产复方倍他米松注射液局部注射治疗瘢痕疙瘩和增生性瘢痕的安全性和疗效,并与进口复方倍他米松注射液(得宝松)进行对照。方法本研究采用多中心、随机肓法、阳性药物平行对照的临床研究方法。受试者分别接受国产复方倍他米松注射液和得宝松注射液治疗。在治疗前、治疗3、6、9周,选择一处无破溃皮损作为观察的靶皮损,观察临床症状和体征。结果本临床试验共入组病例144例,完成试验病例133例,其中对照组64例,试验组69例。试验结束时FAS分析临床疗效有效率(对照组为61.11%,试验组为65.28%,x^2=0.27,P=0.6071)、痊愈率(对照组为2.78%,试验组为0.00%,P=0.4965)提示试验组和对照组疗效相当,经检验差异均无统计学意义(P〉0.05)。安全性方面,试验组共有3例不良反应发生,不良反应发生率为4.17%,两组不良反应发生情况比较差异无统计学意义(P=0.2448)。结论国产复方倍他米松注射液局部注射治疗瘢痕疙瘩和增生性瘢痕安全有效,与得宝松相当。 Objective To compare the safety and efficacy of home-made and imported (diprospan) compound betamethasone injection in the treatment of keloid and hyperp/astic scar. Methods A muhi-center, randomized, blind, positive-controlled, parallel-group clinical study was conducted. Patients with keloid or hyperplastie scar were divided into test and control groups to receive intralesional injection of compound betamethasone made in China and Schering-Plough Labo N.V. Belgium, respectively. A lesion without ulceration was selected as the target lesion for the evaluation of symptom and signs of patients at the beginning of the treatment (DO), on day 21 (D21), 42 (D42) and 63 (D63) after the initiation of treatment. Results A total of 144 patients were enrolled, and 133 patients, including 64 in the control group and 69 in the study group, completed the trial. The improvement rate was 61.11% in the control group and 65.28% in the test group 0(2 = 0.27, P = 0.6071), and the cure rate was 2.78% in the control group, 0.00% in the test group (P =0.4965), indicating that there was no statistically significant difference in the efficiency between the domestic and imported injection (P 〉 0.05). There were 3 (4.17%) cases of adverse reaction in the test group, and no statistical difference was noted in the occurrence of side effects between the two groups (P = 0.2448 ). Conclusion The local injection of domestic compound betamethasone shows a favorable efficacy and sdety, which are comparable to those of diprospan, in the treatment of keloid and hyperplastic sear.
出处 《国际皮肤性病学杂志》 2011年第3期129-131,共3页 International Journal of Dermatology and Venereology
关键词 瘢痕疙瘩 增生 倍他米松 多中心研究 Keloid Hyperplasia Betamethasone Muhicenter studies
  • 相关文献

参考文献6

二级参考文献36

  • 1许惠娟.全反式维A酸胶囊与复方倍他米松软膏治疗结节性痒疹68例疗效比较[J].中华皮肤科杂志,2004,37(6):377-377. 被引量:10
  • 2周万方.药物皮内注射治疗神经性皮炎158例[J].医学理论与实践,1995,8(6):261-262. 被引量:2
  • 3耿铁军.局部注射治疗结节性痒疹[J].中国校医,2006,20(6):616-616. 被引量:3
  • 4Richards RN.Update on intralesional steroid:focus on dermatose.J Cutan Med Surg,2010,14(1):19-23.
  • 5Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg. 1996, 22:126 - 130.
  • 6Lee Y, Minn KW, Baek RM, et al. A new surgical treatment of keloid: keloid core excision. Ann Plast Surg, 2001, 46 : 135 - 140.
  • 7Osswald SS, Elston DM, Vogel PS. Giant right plantar keloid treated ~ith excision and tissue-engineered allograft. J Am Acad Dermatol, 2003. 48:131 - 134.
  • 8Haas AF, Reilly DA. Cultured epithelial autografts in the treatment of exleusive recalcitrant keloids. Arch Dermatol, 1998, 134:549 -552.
  • 9Lahiri A, Tsiliboti D, Gaze NR. Experience with difficult keloids. Br J Plast Surg, 2001,54:633- 635.
  • 10Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic stenlotomy scars: comparison among intralesional eortieosteroid, 5 - fluorouraeil, and 585 - nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol, 2002, 138 : 1149 - 1155.

共引文献77

同被引文献69

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部